CN101479391A - 用于检测cripto-3的组合物及方法 - Google Patents

用于检测cripto-3的组合物及方法 Download PDF

Info

Publication number
CN101479391A
CN101479391A CNA2007800243961A CN200780024396A CN101479391A CN 101479391 A CN101479391 A CN 101479391A CN A2007800243961 A CNA2007800243961 A CN A2007800243961A CN 200780024396 A CN200780024396 A CN 200780024396A CN 101479391 A CN101479391 A CN 101479391A
Authority
CN
China
Prior art keywords
tdgf3
polynucleotide
cripto
sample
antibody
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA2007800243961A
Other languages
English (en)
Chinese (zh)
Inventor
奥利维亚·奥洛兹科
米歇尔·萨尼科拉-纳德尔
尤金·乔伊
约翰·卡勒里
里奇·蒂泽德
苏珊娜·萨克
孙超
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biogen MA Inc
Original Assignee
Biogen Idec MA Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biogen Idec MA Inc filed Critical Biogen Idec MA Inc
Publication of CN101479391A publication Critical patent/CN101479391A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/136—Screening for pharmacological compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Hospice & Palliative Care (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Oncology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
CNA2007800243961A 2006-04-28 2007-04-30 用于检测cripto-3的组合物及方法 Pending CN101479391A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US79580706P 2006-04-28 2006-04-28
US60/795,807 2006-04-28

Publications (1)

Publication Number Publication Date
CN101479391A true CN101479391A (zh) 2009-07-08

Family

ID=38656259

Family Applications (1)

Application Number Title Priority Date Filing Date
CNA2007800243961A Pending CN101479391A (zh) 2006-04-28 2007-04-30 用于检测cripto-3的组合物及方法

Country Status (7)

Country Link
US (1) US20100041032A1 (enExample)
EP (1) EP2021510A2 (enExample)
JP (1) JP2009535033A (enExample)
CN (1) CN101479391A (enExample)
AU (1) AU2007243181A1 (enExample)
CA (1) CA2650379A1 (enExample)
WO (1) WO2007127461A2 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4307845B2 (ja) * 2001-04-26 2009-08-05 バイオジェン・アイデック・エムエイ・インコーポレイテッド Ｃｒｉｐｔｏをブロックする抗体およびその使用
US20050163782A1 (en) 2003-06-27 2005-07-28 Biogen Idec Ma Inc. Modified binding molecules comprising connecting peptides
WO2006074397A2 (en) * 2005-01-05 2006-07-13 Biogen Idec Ma Inc. Cripto binding molecules

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5210015A (en) * 1990-08-06 1993-05-11 Hoffman-La Roche Inc. Homogeneous assay system using the nuclease activity of a nucleic acid polymerase
US5264557A (en) * 1991-08-23 1993-11-23 The United States Of America As Represented By The Department Of Health And Human Services Polypeptide of a human cripto-related gene, CR-3
WO2000052204A2 (en) * 1999-02-22 2000-09-08 Orntoft Torben F Gene expression in bladder tumors
GB0020953D0 (en) * 2000-08-24 2000-10-11 Smithkline Beecham Biolog Vaccine
NZ525380A (en) * 2000-09-18 2008-06-30 Biogen Idec Inc Non-fucosylated forms of Cripto and their use as tumor blocking agents
EP1494693B1 (en) * 2002-03-22 2010-12-08 Biogen Idec MA Inc. Cripto-specific antibodies

Also Published As

Publication number Publication date
US20100041032A1 (en) 2010-02-18
WO2007127461A2 (en) 2007-11-08
WO2007127461A3 (en) 2008-06-26
AU2007243181A1 (en) 2007-11-08
EP2021510A2 (en) 2009-02-11
JP2009535033A (ja) 2009-10-01
CA2650379A1 (en) 2007-11-08

Similar Documents

Publication Publication Date Title
KR101828290B1 (ko) 자궁내막암 마커
US8062892B2 (en) Genes, compositions, kits, and methods for identification, assessment, prevention and therapy of cervical cancer
US20100105051A1 (en) Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer
JP5937017B2 (ja) Ａｌｋ阻害剤に対する自然耐性または獲得耐性を有する癌の同定、評価および治療法
PT1994410E (pt) Métodos e estojos para detecção precoce de cancro ou de predisposição a este
EP1784511A2 (en) Genes, compositions, kits, and methods for identification, assessment, prevention, and therapy of prostate cancer
CA2504903A1 (en) Method for identifying risk of melanoma and treatments thereof
US20030215805A1 (en) Novel genes, compositions, kits, and methods for identification, assessment prevention, and therapy of breast cancer
CA2687997A1 (en) Diagnostic methods and markers
DK2148932T3 (en) SOX11 expression in malignant lymphomas
CN101479391A (zh) 用于检测cripto-3的组合物及方法
US7883896B2 (en) Marker molecules associated with lung tumors
EP1365030A1 (en) G-protein coupled receptor marker molecules associated with colorectal lesions
WO2015194524A1 (ja) Ｂ前駆細胞性急性リンパ芽球性白血病新規キメラ遺伝子
US20060122132A1 (en) Use of murine genomic regions identified to be involved in tumor developement for the development of anti-cancer drugs and diagnosis of cancer
KR101683961B1 (ko) 방광암 재발 진단 마커
CN101684499A (zh) 诊断和治疗与人转酮酶样-1基因过表达有关的增殖异常的组合物和方法

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20090708